-
JANX Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Janux Therapeutics (JANX)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|
Revenue | ||||
Cost of revenue | ||||
Operating income | ||||
Operating margin | ||||
Net income | ||||
Net profit margin | ||||
Cash on hand | ||||
Change in cash | ||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 27.57 mm | 27.57 mm | 27.57 mm | 27.57 mm | 27.57 mm | 27.57 mm |
Cash burn (monthly) | (no burn) | (no burn) | 11.95 mm | 7.16 mm | 743.67 k | 3.08 mm |
Cash used (since last report) | n/a | n/a | 48.06 mm | 28.81 mm | 2.99 mm | 12.40 mm |
Cash remaining | n/a | n/a | -20.49 mm | -1.24 mm | 24.58 mm | 15.17 mm |
Runway (months of cash) | n/a | n/a | -1.7 | -0.2 | 33.1 | 4.9 |
13F holders | Current |
---|---|
Total holders | 163 |
Opened positions | 35 |
Closed positions | 29 |
Increased positions | 55 |
Reduced positions | 50 |
13F shares | Current |
---|---|
Total value | 2.02 tn |
Total shares | 51.64 mm |
Total puts | 653.70 k |
Total calls | 85.30 k |
Total put/call ratio | 7.7 |
Largest owners | Shares | Value |
---|---|---|
Ra Capital Management | 9.17 mm | $416.40 bn |
FMR | 7.82 mm | $355.47 bn |
Avalon Ventures XI | 3.02 mm | $150.74 mm |
Bregua | 3.00 mm | $167.85 mm |
JHG Janus Henderson | 2.52 mm | $114.59 bn |
BlackRock | 2.42 mm | $110.06 bn |
Paradigm Biocapital Advisors | 2.40 mm | $109.06 bn |
Adage Capital Partners GP, L.L.C. | 2.08 mm | $94.27 bn |
Vanguard | 1.85 mm | $83.95 bn |
Woodline Partners | 1.60 mm | $72.70 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
7 Jan 25 | David Alan Campbell | Common Stock | Sell | Dispose S | No | Yes | 60.0008 | 5,000 | 300.00 k | 293,054 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 57.365 | 200 | 11.47 k | 82,139 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 56.7778 | 1,000 | 56.78 k | 82,339 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 55.7587 | 3,444 | 192.03 k | 83,339 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 54.5111 | 5,768 | 314.42 k | 86,783 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Sell | Dispose S | No | Yes | 53.7582 | 2,922 | 157.08 k | 92,551 |
2 Jan 25 | Andrew Hollman Meyer | Common Stock | Grant | Acquire A | No | No | 0 | 18,000 | 0.00 | 95,473 |
2 Jan 25 | Andrew Hollman Meyer | Stock option Common Stock | Grant | Acquire A | No | No | 53.24 | 63,000 | 3.35 mm | 63,000 |
2 Jan 25 | Byron Robinson | Common Stock | Grant | Acquire A | No | No | 0 | 28,000 | 0.00 | 28,000 |
2 Jan 25 | Byron Robinson | Stock option Common Stock | Grant | Acquire A | No | No | 53.24 | 98,000 | 5.22 mm | 98,000 |